NCM
PFE icon

NCM Capital Management’s Pfizer PFE Stock Holding History

NCM Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$929K Buy
38,580
+11,881
+44% +$311K 0.29% 82
2026
Q1 		$750K Buy
26,699
+5
+0% +$133 0.27% 91
2025
Q4 		$665K Sell
26,694
-2,616
-9% -$66K 0.25% 99
2025
Q3 		$747K Sell
29,310
-1,758
-6% -$43.4K 0.29% 82
2025
Q2 		$753K Buy
31,068
+7
+0% +$163 0.31% 78
2025
Q1 		$787K Sell
31,061
-194
-0.6% -$5.08K 0.35% 73
2024
Q4 		$829K Sell
31,255
-996
-3% -$27K 0.37% 65
2024
Q3 		$933K Buy
32,251
+5
+0% +$146 0.45% 54
2024
Q2 		$902K Sell
32,246
-2,277
-7% -$62.7K 0.47% 48
2024
Q1 		$958K Buy
34,523
+4,314
+14% +$120K 0.54% 49
2023
Q4 		$870K Sell
30,209
-1,278
-4% -$38.6K 0.53% 53
2023
Q3 		$1.04M Sell
31,487
-286
-0.9% -$10.1K 0.74% 33
2023
Q2 		$1.17M Buy
31,773
+43
+0.1% +$1.67K 0.81% 29
2023
Q1 		$1.29M Buy
31,730
+3,141
+11% +$136K 0.97% 24
2022
Q4 		$1.47M Sell
28,589
-270
-0.9% -$12.9K 0.97% 26
2022
Q3 		$1.26M Sell
28,859
-166
-0.6% -$8.07K 0.96% 28
2022
Q2 		$1.52M Sell
29,025
-170
-0.6% -$8.66K 1.07% 27
2022
Q1 		$1.51M Sell
29,195
-401
-1% -$20.8K 0.95% 26
2021
Q4 		$1.75M Buy
+29,596
New +$1.47M 1.55% 12

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

NCM Capital Management's PFE Position: Q2 2026 in Review

NCM Capital Management increased its Pfizer (PFE) stake by 44% in Q2 2026, buying an estimated $311K and bringing the position to 38,580 shares worth $929K. The position accounts for 0.29% of the portfolio, ranked #82.

NCM Capital Management first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.75M in Q4 2021. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • NCM Capital Management held 38,580 shares of Pfizer worth $929K as of Q2 2026.
  • NCM Capital Management bought 11,881 Pfizer shares in Q2 2026, an estimated $311K.
  • Pfizer made up 0.29% of NCM Capital Management's portfolio in Q2 2026, its #82 holding.
  • NCM Capital Management first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • NCM Capital Management's Pfizer position peaked at $1.75M in Q4 2021.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on NCM Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.